License for Use of "Physicians' Current Procedural Terminology", (CPT) Fourth Edition

End User/Point and Click Agreement: CPT codes, descriptions and other data only are copyright 2009 American Medical Association (AMA). All Rights Reserved (or such other date of publication of CPT). CPT is a trademark of the AMA.

You, your employees and agents are authorized to use CPT only as contained in the following authorized materials including but not limited to CGS fee schedules, general communications, Medicare Bulletin, and related materials internally within your organization within the United States for the sole use by yourself, employees, and agents. Use is limited to use in Medicare, Medicaid, or other programs administered by the Centers for Medicare & Medicaid Services (CMS). You agree to take all necessary steps to insure that your employees and agents abide by the terms of this agreement.

Any use not authorized herein is prohibited, including by way of illustration and not by way of limitation, making copies of CPT for resale and/or license, transferring copies of CPT to any party not bound by this agreement, creating any modified or derivative work of CPT, or making any commercial use of CPT. License to use CPT for any use not authorized here in must be obtained through the AMA, CPT Intellectual Property Services, 515 N. State Street, Chicago, IL 60610. Applications are available at the AMA website.

This product includes CPT which is commercial technical data and/or computer data bases and/or commercial computer software and/or commercial computer software documentation, as applicable which were developed exclusively at private expense by the American Medical Association, 515 North State Street, Chicago, Illinois, 60610. U.S. Government rights to use, modify, reproduce, release, perform, display, or disclose these technical data and/or computer data bases and/or computer software and/or computer software documentation are subject to the limited rights restrictions of DFARS 252.227-7015(b)(2)(June 1995) and/or subject to the restrictions of DFARS 227.7202-1(a)(June 1995) and DFARS 227.7202-3(a)June 1995), as applicable for U.S. Department of Defense procurements and the limited rights restrictions of FAR 52.227-14 (June 1987) and/or subject to the restricted rights provisions of FAR 52.227-14 (June 1987) and FAR 52.227-19 (June 1987), as applicable, and any applicable agency FAR Supplements, for non-Department Federal procurements.

AMA Disclaimer of Warranties and Liabilities.

CPT is provided "as is" without warranty of any kind, either expressed or implied, including but not limited to, the implied warranties of merchantability and fitness for a particular purpose. AMA warrants that due to the nature of CPT, it does not manipulate or process dates, therefore there is no Year 2000 issue with CPT. AMA disclaims responsibility for any errors in CPT that may arise as a result of CPT being used in conjunction with any software and/or hardware system that is not Year 2000 compliant. No fee schedules, basic unit, relative values or related listings are included in CPT. The AMA does not directly or indirectly practice medicine or dispense medical services. The responsibility for the content of this file/product is with CGS or the CMS and no endorsement by the AMA is intended or implied. The AMA disclaims responsibility for any consequences or liability attributable to or related to any use, non-use, or interpretation of information contained or not contained in this file/product. This Agreement will terminate upon notice if you violate its terms. The AMA is a third party beneficiary to this Agreement.

CMS Disclaimer

The scope of this license is determined by the AMA, the copyright holder. Any questions pertaining to the license or use of the CPT must be addressed to the AMA. End Users do not act for or on behalf of the CMS. CMS DISCLAIMS RESPONSIBILITY FOR ANY LIABILITY ATTRIBUTABLE TO END USER USE OF THE CPT. CMS WILL NOT BE LIABLE FOR ANY CLAIMS ATTRIBUTABLE TO ANY ERRORS, OMISSIONS, OR OTHER INACCURACIES IN THE INFORMATION OR MATERIAL CONTAINED ON THIS PAGE. In no event shall CMS be liable for direct, indirect, special, incidental, or consequential damages arising out of the use of such information or material.

This license will terminate upon notice to you if you violate the terms of this license. The AMA is a third party beneficiary to this license.

POINT AND CLICK LICENSE FOR USE OF "CURRENT DENTAL TERMINOLOGY", ("CDT")

End User License Agreement

THE LICENSE GRANTED HEREIN IS EXPRESSLY CONDITIONED UPON YOUR ACCEPTANCE OF ALL TERMS AND CONDITIONS CONTAINED IN THIS AGREEMENT. BY CLICKING BELOW ON THE BUTTON LABELED "I ACCEPT", YOU HEREBY ACKNOWLEDGE THAT YOU HAVE READ, UNDERSTOOD AND AGREED TO ALL TERMS AND CONDITIONS SET FORTH IN THIS AGREEMENT.

IF YOU DO NOT AGREE WITH ALL TERMS AND CONDITIONS SET FORTH HEREIN, CLICK BELOW ON THE BUTTON LABELED "I DO NOT ACCEPT" AND EXIT FROM THIS COMPUTER SCREEN.

IF YOU ARE ACTING ON BEHALF OF AN ORGANIZATION, YOU REPRESENT THAT YOU ARE AUTHORIZED TO ACT ON BEHALF OF SUCH ORGANIZATION AND THAT YOUR ACCEPTANCE OF THE TERMS OF THIS AGREEMENT CREATES A LEGALLY ENFORCEABLE OBLIGATION OF THE ORGANIZATION. AS USED HEREIN, "YOU" AND "YOUR" REFER TO YOU AND ANY ORGANIZATION ON BEHALF OF WHICH YOU ARE ACTING.

Subject to the terms and conditions contained in this Agreement, you, your employees, and agents are authorized to use CDT-4 only as contained in the following authorized materials and solely for internal use by yourself, employees and agents within your organization within the United States and its territories. Use of CDT-4 is limited to use in programs administered by Centers for Medicare & Medicaid Services (CMS). You agree to take all necessary steps to ensure that your employees and agents abide by the terms of this agreement. You acknowledge that the ADA holds all copyright, trademark and other rights in CDT-4. You shall not remove, alter, or obscure any ADA copyright notices or other proprietary rights notices included in the materials.
Any use not authorized herein is prohibited, including by way of illustration and not by way of limitation, making copies of CDT-4 for resale and/or license, transferring copies of CDT-4 to any party not bound by this agreement, creating any modified or derivative work of CDT-4, or making any commercial use of CDT-4. License to use CDT-4 for any use not authorized herein must be obtained through the American Dental Association, 211 East Chicago Avenue, Chicago, IL 60611. Applications are available at the American Dental Association website.
Applicable Federal Acquisition Regulation Clauses (FARS)\Department of Defense Federal Acquisition Regulation Supplement (DFARS) Restrictions Apply to Government use. Please click here to see all U.S. Government Rights Provisions.
ADA DISCLAIMER OF WARRANTIES AND LIABILITIES. CDT-4 is provided "as is" without warranty of any kind, either expressed or implied, including but not limited to, the implied warranties of merchantability and fitness for a particular purpose. No fee schedules, basic unit, relative values or related listings are included in CDT-4. The ADA does not directly or indirectly practice medicine or dispense dental services. The sole responsibility for the software, including any CDT-4 and other content contained therein, is with (insert name of applicable entity) or the CMS; and no endorsement by the ADA is intended or implied. The ADA expressly disclaims responsibility for any consequences or liability attributable to or related to any use, non-use, or interpretation of information contained or not contained in this file/product. This Agreement will terminate upon notice to you if you violate the terms of this Agreement. The ADA is a third-party beneficiary to this Agreement.
CMS DISCLAIMER. The scope of this license is determined by the ADA, the copyright holder. Any questions pertaining to the license or use of the CDT-4 should be addressed to the ADA. End users do not act for or on behalf of the CMS. CMS DISCLAIMS RESPONSIBILITY FOR ANY LIABILITY ATTRIBUTABLE TO END USER USE OF THE CDT-4. CMS WILL NOT BE LIABLE FOR ANY CLAIMS ATTRIBUTABLE TO ANY ERRORS, OMISSIONS, OR OTHER INACCURACIES IN THE INFORMATION OR MATERIAL COVERED BY THIS LICENSE. In no event shall CMS be liable for direct, indirect, special, incidental, or consequential damages arising out of the use of such information or material.

The license granted herein is expressly conditioned upon your acceptance of all terms and conditions contained in this agreement. If the foregoing terms and conditions are acceptable to you, please indicate your agreement by clicking below on the button labeled "I ACCEPT". If you do not agree to the terms and conditions, you may not access or use the software. Instead, you must click below on the button labeled "I DO NOT ACCEPT" and exit from this computer screen.

Print | Bookmark | Email | Font Size: + | –

Billing Osteoporosis Drugs for Home Health Beneficiaries

Home health consolidated billing rules require the primary home health agency (HHA) to bill osteoporosis drugs for beneficiaries meeting coverage requirements for these drugs and who are under their care for a 60-day episode or 30-day period of care under the Patient-Driven Groupings Model (PDGM). Osteoporosis drugs are excluded from reimbursement under the Home Health Prospective Payment System (HH PPS), and instead, are paid on a reasonable cost basis. Refer to the Centers for Medicare & Medicaid Services (CMS) Pub. 100-04, Ch. 10, Section 90.1 for additional information.

Reimbursement for administering the drug is included in the charge for the skilled nursing visit. The primary HHA submits these charges with other skilled nursing visits billed on the claim – TOB (type of bill) 329 – along with all other home health-related services provided by the HHA during the period of care. The Osteoporosis drug is billed with the TOB 034X, using revenue code 0636.

In order for the home health agency to bill Medicare, the beneficiary must be entitled to Medicare Part B. In addition, Medicare requires that the date of service on a claim for covered osteoporosis drugs falls within the start and end dates of an existing home health PPS episode. The provider number on the claim for osteoporosis drugs must also match the provider number that established the home health episode during which the drug was administered. HHAs should be aware that if Medicare denies the skilled nursing visit during which the osteoporosis drug was administered, the charges for the drug will not be paid by Medicare.

Osteoporosis drugs can be submitted via the Fiscal Intermediary Standard System (FISS) Direct Data Entry (DDE) using the Home Health Claims Entry option 26 (accessible from FISS Main Menu option 02). See Chapter 4 – Claims and Attachments Menu of the Fiscal Intermediary Standard System (FISS) Guide for information on entering Medicare claims using FISS.

In addition to the usual information that is required on Medicare claims, the following identifies specific information required for HHAs to submit osteoporosis drugs to Medicare.

Field Name	Description
TOB	34X – HHA visits provided on an outpatient basis. ('X' denotes the frequency of bill.) Frequency indicators are accessible from the National Uniform Billing Committee (NUBC) Official UB-04 Data Specifications Manual – http://www.nubc.org/
STMT DATES FROM/TO	Enter the dates of service for the billing period. NOTE: these should fall within the "FROM" and "TO" dates for the HH PPS episode of care or HH PDGM for claims with a "From" date on or after January 1, 2020, provided by the primary HHA.
REV	Enter revenue code: 0636 – Pharmacy – Extension of 025X – Drugs requiring detailed coding.
HCPC	Enter the appropriate HCPCS code: J0630 – Drugs containing calcitonin J3110 – Drugs containing teriparatide J3490 – Drugs that are FDA approved and awaiting a specific HCPCS code Effective with dates of service on or after January 1, 2021: J0897 – Drugs containing denosumab J3111 – Drugs containing romosozumab-aqqg (effective with dates of service on or after January 1, 2020) J3590 – Drugs containing abaloparatide
TOT UNIT/COV UNIT	Enter units as defined by HCPCS code: J0630 – 1 unit for every 100-400 units furnished during billing period 2 units for every 401-800 units furnished during billing period 3 units for every 801-1200 units furnished during billing period 4 units for every 1201-1600 units furnished during billing period 5 units for every 1601-2000 units furnished during billing period 6 units for every 2001-2400 units furnished during billing period J3110 – Report 1 unit for every 10 mcg furnished during billing period J3490 – Report units as defined by HCPCS code
TOT CHARGES	Enter the charge per revenue code for the osteoporosis drug.
SERV DATE	Enter the line item date of service the drug was provided.
DIAG CODES	Enter the ICD-10 code M810 for services on or after October 1, 2015. Others as required to describe bone fracture sustained due to post-menopausal osteoporosis

Coverage requirements for osteoporosis drugs are found in the Medicare Benefit Policy Manual (Pub. 100-02, Chapter 7, §50.4.3). See the CGS Calcitonin and Forteo webpage for more coverage information on these osteoporosis drugs. Additional information may be accessed from the Medicare Claims Processing Manual (Pub. 100-04, Chapter 10, § 10, 20 and 90.1).

Resources:

MM11846 – Update to Osteoporosis Drug Codes Billable on Home Health Claims

Updated: 02.xx.2021

heir care for a 60-day episode or 30-day period of care under the Patient-Driven Groupings Model (PDGM). Osteoporosis drugs are excluded from reimbursement under the Home Health Prospective Payment System (HH PPS), and instead, are paid on a reasonable cost basis. Refer to the Centers for Medicare & Medicaid Services (CMS) Pub. 100-04, Ch. 10, Section 90.1 for additional information.